Form 13G Tenax Therapeutics For: 23 December
- Investing.com
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Tenax Therapeutics Inc (TENX)
Assess today's live Tenax Therapeutics Inc (TENX) share price, performance and insights using our live NASDAQ: TENX stock exchange data.
Analyse the historical data and Tenax Therapeutics Inc share price performance charts on this page. Our technical summary section provides analysis on Tenax Therapeutics share price buy/sell indicators using real-time data (or discuss the Tenax Therapeutics (TENX) stock price today with other investors in the Tenax Therapeutics NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ TENX share price (ISIN: US88032L6056) to enhance your trading decisions with our free investment tools and resources.
What Is the Tenax Therapeutics Inc Share Price Today?
The Tenax Therapeutics share price today is 11.9600.
What Is the Stock Symbol for Tenax Therapeutics Inc
The stock symbol (or 'ticker') for Tenax Therapeutics Inc is "TENX."
What Stock Exchange Does Tenax Therapeutics Inc Trade On?
Tenax Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Tenax Therapeutics Inc a Good Stock to Buy?
Determining whether Tenax Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Tenax Therapeutics Inc share price performance charts on this page. Our technical summary section provides analysis on Tenax Therapeutics share price buy/sell indicators using real-time data (or discuss the Tenax Therapeutics (TENX) stock price today with other investors in the Tenax Therapeutics NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ TENX share price (ISIN: US88032L6056) to enhance your trading decisions with our free investment tools and resources.
What Is the Tenax Therapeutics Inc Share Price Today?
The Tenax Therapeutics share price today is 11.9600.
What Is the Stock Symbol for Tenax Therapeutics Inc
The stock symbol (or 'ticker') for Tenax Therapeutics Inc is "TENX."
What Stock Exchange Does Tenax Therapeutics Inc Trade On?
Tenax Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Tenax Therapeutics Inc a Good Stock to Buy?
Determining whether Tenax Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
11.9100
13.3500
52 wk Range
4.6300
14.2200
TENX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
11.910013.3500
52 wk Range
4.630014.2200
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
TENX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
22.9040
Upside
+91.51%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in overbought territory
- Form 13G TENAX THERAPEUTICS For: 8 December
- Investing.com
- Form 13G Tenax Therapeutics For: 23 December
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Tenax Therapeutics Company Profile
Tenax Therapeutics, Inc., a clinical-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States. It develops TNX-101, TNX-102, and TNX-103 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension in heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is based in Chapel Hill, North Carolina.
Compare TENX to Peers and Sector
Metrics to compare | TENX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTENXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −11.2x | −2.1x | −0.6x | |
PEG Ratio | −0.22 | 0.02 | 0.00 | |
Price/Book | 5.0x | 2.4x | 2.6x | |
Price / LTM Sales | - | 193.6x | 3.2x | |
Upside (Analyst Target) | 109.0% | 31.7% | 41.8% | |
Fair Value Upside | Unlock | 3.1% | 5.1% | Unlock |
Analyst Ratings
5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 22.9040
(+91.51% Upside)
Earnings
Latest Release
Nov 12, 2025
EPS / Forecast
-0.40 / -0.23
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Tenax Therapeutics (TENX) Share Price Today?
The live Tenax Therapeutics share price today is 11.9600
What Stock Exchange Does Tenax Therapeutics (TENX) Trade On?
Tenax Therapeutics is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Tenax Therapeutics?
The stock symbol (also called a 'ticker') for Tenax Therapeutics is "TENX."
What Is the Current Tenax Therapeutics Market Cap?
As of today, Tenax Therapeutics market capitalisation is 485.22M.
What Is Tenax Therapeutics's (TENX) Earnings Per Share (TTM)?
The Tenax Therapeutics EPS is currently -1.14 (Trailing Twelve Months).
Is TENX a Buy or Sell From a Technical Analyst Perspective?
Based on today's Tenax Therapeutics moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Tenax Therapeutics Stock Split?
Tenax Therapeutics has split 5 times. (See the TENX stock split history page for full effective split date and price information.)
How Many Employees Does Tenax Therapeutics Have?
Tenax Therapeutics has 5 employees.
What is the current trading status of Tenax Therapeutics (TENX)?
As of 24 Dec 2025, Tenax Therapeutics (TENX) is trading at a price of 11.9600, with a previous close of 12.4600. The stock has fluctuated within a day range of 11.9100 to 13.3500, while its 52-week range spans from 4.6300 to 14.2200.
What Is Tenax Therapeutics (TENX) Price Target According to Analysts?
The average 12-month price target for Tenax Therapeutics is USD22.904, with a high estimate of USD30 and a low estimate of USD13.52. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +91.51% Upside potential.
What Is the TENX After Hours Price?
TENX's last after hours stock price is 12.0600, the stock has decreased by 0.1000, or 0.8400%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.